Caveolae couple mechanical stress to integrin recycling and activation

  1. Fidel-Nicolás Lolo
  2. Dácil María Pavón
  3. Araceli Grande
  4. Alberto Elósegui Artola
  5. Valeria Inés Segatori
  6. Sara Sánchez
  7. Xavier Trepat
  8. Pere Roca-Cusachs
  9. Miguel Ángel del Pozo  Is a corresponding author
  1. Centro Nacional de Investigaciones Cardiovasculares, Spain
  2. Allergy Therapeutics S.L., Spain
  3. The Francis Crick Institute, United Kingdom
  4. Quilmes National University, Argentina
  5. Institute for Bioengineering of Catalonia, Spain

Abstract

Cells are subjected to multiple mechanical inputs throughout their lives. Their ability to detect these environmental cues is called mechanosensing, a process in which integrins play an important role. During cellular mechanosensing, plasma membrane (PM) tension is adjusted to mechanical stress through the buffering action of caveolae; however, little is known about the role of caveolae in early integrin mechanosensing regulation. Here, we show that Cav1KO fibroblasts increase adhesion to FN-coated beads when pulled with magnetic tweezers, as compared to wild type fibroblasts. This phenotype is Rho-independent and mainly derived from increased active b1-integrin content on the surface of Cav1KO fibroblasts. FRAP analysis and endocytosis/recycling assays revealed that active b1-integrin is mostly endocytosed through the CLIC/GEEC pathway and is more rapidly recycled to the PM in Cav1KO fibroblasts, in a Rab4 and PM tension-dependent manner. Moreover, the threshold for PM tension-driven b1-integrin activation is lower in Cav1KO MEFs than in wild type MEFs, through a mechanism dependent on talin activity. Our findings suggest that caveolae couple mechanical stress to integrin cycling and activation, thereby regulating the early steps of the cellular mechanosensing response.

Data availability

Raw data of all figures is included as excel files

Article and author information

Author details

  1. Fidel-Nicolás Lolo

    Cell and developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1635-4770
  2. Dácil María Pavón

    Allergy Therapeutics S.L., Alcalá de Henares, Spain
    Competing interests
    Dácil María Pavón, is affiliated with Allergy Therapeutics S.L. The author has no financial interests to declare.
  3. Araceli Grande

    Structural Biology Programme, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2619-5013
  4. Alberto Elósegui Artola

    The Francis Crick Institute, London, United Kingdom
    Competing interests
    No competing interests declared.
  5. Valeria Inés Segatori

    Quilmes National University, Buenos Aires, Argentina
    Competing interests
    No competing interests declared.
  6. Sara Sánchez

    Cell and developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
    Competing interests
    No competing interests declared.
  7. Xavier Trepat

    Institute for Bioengineering of Catalonia, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7621-5214
  8. Pere Roca-Cusachs

    Institute for Bioengineering of Catalonia, Barcelona, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6947-961X
  9. Miguel Ángel del Pozo

    Cell and developmental Biology Area, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
    For correspondence
    madelpozo@cnic.es
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9077-391X

Funding

European Union Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie grant 641639)

  • Miguel Ángel del Pozo

Spanish Ministry of Science and Innovation (PID2020-118658RB-I00,SAF2014-51876-R,SAF2017-83130-R,PDC2021-121572-100,CSD2009-0016)

  • Miguel Ángel del Pozo

Worldwide Cancer Research Foundation (#15 -0404)

  • Miguel Ángel del Pozo

Asociación Española Contra el Cáncer Foundation (PROYE20089DELP)

  • Miguel Ángel del Pozo

Spanish Ministry of Science and Innovation (BFU2016-81912-REDC)

  • Miguel Ángel del Pozo

Fundació la Marató de TV3 (674/C/2013)

  • Pere Roca-Cusachs
  • Miguel Ángel del Pozo

Fundació la Marató de TV3 (201936-30-31)

  • Pere Roca-Cusachs
  • Miguel Ángel del Pozo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Lolo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,457
    views
  • 407
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fidel-Nicolás Lolo
  2. Dácil María Pavón
  3. Araceli Grande
  4. Alberto Elósegui Artola
  5. Valeria Inés Segatori
  6. Sara Sánchez
  7. Xavier Trepat
  8. Pere Roca-Cusachs
  9. Miguel Ángel del Pozo
(2022)
Caveolae couple mechanical stress to integrin recycling and activation
eLife 11:e82348.
https://doi.org/10.7554/eLife.82348

Share this article

https://doi.org/10.7554/eLife.82348

Further reading

    1. Cell Biology
    Tamás Visnovitz, Dorina Lenzinger ... Edit I Buzas
    Short Report

    Recent studies showed an unexpected complexity of extracellular vesicle (EV) biogenesis pathways. We previously found evidence that human colorectal cancer cells in vivo release large multivesicular body-like structures en bloc. Here, we tested whether this large EV type is unique to colorectal cancer cells. We found that all cell types we studied (including different cell lines and cells in their original tissue environment) released multivesicular large EVs (MV-lEVs). We also demonstrated that upon spontaneous rupture of the limiting membrane of the MV-lEVs, their intraluminal vesicles (ILVs) escaped to the extracellular environment by a ‘torn bag mechanism’. We proved that the MV-lEVs were released by ectocytosis of amphisomes (hence, we termed them amphiectosomes). Both ILVs of amphiectosomes and small EVs separated from conditioned media were either exclusively CD63 or LC3B positive. According to our model, upon fusion of multivesicular bodies with autophagosomes, fragments of the autophagosomal inner membrane curl up to form LC3B positive ILVs of amphisomes, while CD63 positive small EVs are of multivesicular body origin. Our data suggest a novel common release mechanism for small EVs, distinct from the exocytosis of multivesicular bodies or amphisomes, as well as the small ectosome release pathway.

    1. Cell Biology
    2. Genetics and Genomics
    Adam D Longhurst, Kyle Wang ... David P Toczyski
    Tools and Resources

    Progression through the G1 phase of the cell cycle is the most highly regulated step in cellular division. We employed a chemogenetic approach to discover novel cellular networks that regulate cell cycle progression. This approach uncovered functional clusters of genes that altered sensitivity of cells to inhibitors of the G1/S transition. Mutation of components of the Polycomb Repressor Complex 2 rescued proliferation inhibition caused by the CDK4/6 inhibitor palbociclib, but not to inhibitors of S phase or mitosis. In addition to its core catalytic subunits, mutation of the PRC2.1 accessory protein MTF2, but not the PRC2.2 protein JARID2, rendered cells resistant to palbociclib treatment. We found that PRC2.1 (MTF2), but not PRC2.2 (JARID2), was critical for promoting H3K27me3 deposition at CpG islands genome-wide and in promoters. This included the CpG islands in the promoter of the CDK4/6 cyclins CCND1 and CCND2, and loss of MTF2 lead to upregulation of both CCND1 and CCND2. Our results demonstrate a role for PRC2.1, but not PRC2.2, in antagonizing G1 progression in a diversity of cell linages, including chronic myeloid leukemia (CML), breast cancer, and immortalized cell lines.